This portable camping lantern casts a warm glow around your campsite or backyard, but it also doubles as a Bluetooth speaker ...

Halozyme Therapeutics logged a -12.9% change during today's morning session, and is now trading at a price of $47.01 per ...

Halozyme Therapeutics (NASDAQ:HALO) fell 14% after confirming on Thursday that it made an €11 per share bid for Evotec .

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

In a recent interview, Microsoft Gaming CEO Phil Spencer had some compelling things to say about the future of the Halo ...

Halozyme Therapeutics said on Thursday it has proposed to buy German drug developer Evotec for about 2 billion euros ($2.10 billion), to bulk up its drug discovery and development portfolio.

Bela Karolyi, who led Nadia Comaneci and Mary Lou Retton to Olympic gymnastics gold, dies 5 Cars To Buy in 2025 That Will Last Through Retirement Paul Carries Immobile Tyson For Lopsided Win Always ...

Earlier this year, Xbox brought some of its games to PlayStation 5 and Switch. Apparently that worked pretty well, as ...

The two-row midsized Honda Passport SUV is redesigned for 2026 with more rugged looks and an updated V6 engine.

Black Ops 6 players are desperate to splash the cash on the leaked Master Chief skin that is supposedly coming in the near ...

Van ECK Associates Corp reduced its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 35.5% in the 3rd quarter, according to the company in its most recent 13F filing with the ...